Partnering

Solving for complex diseases requires a concerted effort.

Parthenon operates at the intersection of precision medicine, systems biology, pharmacology, big data, and machine learning to discover and develop breakthrough medicines and novel combination approaches to beat cancer and other diseases for which there are no cures today.

We’ve assembled a world-class team of scientists with diverse backgrounds and experience committed to beating recalcitrant diseases. We believe that our goals are ambitious and therefore need to be addressed through a structured, positive, collaborative environment with partners who share our values.

We work with academia, patient associations, and pharma/biotech to solve the toughest problems.

Let’s collaborate and bend the curve of diseases together.

New partnership opportunities

Parthenon strongly believes in the opportunities created by collaborations – from optimization of Parthenon’s proprietary machine learning algorithms to systems biology screens and drug development activities, we are interested in developing mutually beneficial partnerships consistent with our values, vision, and mission.